Education
About Us
Working with TipRanks
Follow Us
Ensysce Biosciences (ENSC)
NASDAQ:ENSC
Total Valuation
Ensysce Biosciences has a market cap or net worth of $3.23M. The enterprise value is -$1.73M.
Market Cap$3.23M
Enterprise Value-$1.73M
Share Statistics
Ensysce Biosciences has 1.72M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1.72M
Owened by Insiders
Owened by Instutions9.94%
Financial Efficiency
Ensysce Biosciences’s return on equity (ROE) is -2.15 and return on invested capital (ROIC) is -195.69%.
Return on Equity (ROE)-215.38%
Return on Assets (ROA)-142699552.21%
Return on Invested Capital (ROIC)-195.69%
Return on Capital Employed (ROCE)304.92%
Revenue Per Employee$69,645.571
Profits Per Employee-$1,140,990.714
Employee Count7
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Ensysce Biosciences is >-0.01. Ensysce Biosciences’s PEG ratio is >-0.01.
PE Ratio>-0.01
PS Ratio0.00
PB Ratio<0.01
Price to Fair Value<0.01
Price to FCF>-0.01
Price to Operating Cash Flow>-0.01
PEG Ratio>-0.01
Income Statement
In the last 12 months, Ensysce Biosciences had revenue of $487.52K and earned -$7.99M in profits. Earnings per share was -$5.10.
Revenue$487.52K
Gross Profit-$459.71K
Operating Income-$6.73M
Pretax Income-$7.99M
Net Income-$7.99M
EBITDA-4.83M
Earnings Per Share (EPS)-5.10
Cash Flow
In the last 12 months, operating cash flow was -$7.50M and capital expenditures $0.00, giving a free cash flow of -$7.50M billion.
Operating Cash Flow-$7.50M
Free Cash Flow-$7.50M
Free Cash Flow per Share-$4.36
Dividends & Yields
Ensysce Biosciences pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-52771957.22%
Earnings Yield-56179974.68%
Stock Price Statistics
Beta0.71
52-Week Price Change-80.08%
50-Day Moving Average4.43
200-Day Moving Average6.10
Relative Strength Index (RSI)19.41
Average Volume (3m)39.17K
Important Dates
Ensysce Biosciences upcoming earnings date is May 19, 2025, After Close.
Last Earnings DateMar 10, 2025
Next Earnings DateMay 19, 2025
Ex-Dividend Date―
Financial Position
Ensysce Biosciences as a current ratio of 2.42, with Debt / Equity ratio of 0.08
Current Ratio2.42
Quick Ratio2.42
Debt to Market Cap21.22K
Net Debt to EBITDA-0.04
Interest Coverage Ratio5.22
Taxes
In the past 12 months, Ensysce Biosciences has paid -$74.00 in taxes.
Income Tax-$74.00
Effective Tax Rate0.00%
Enterprise Valuation
Ensysce Biosciences EV to EBITDA ratio is -0.04, with an EV/FCF ratio of -0.04.
EV to Sales0.00
EV to EBITDA-0.04
EV to Free Cash Flow-0.04
EV to Operating Cash Flow-0.04
Balance Sheet
Ensysce Biosciences has $3.50M in cash and marketable securities with $301.66K in debt, giving a net cash position of -$3.20M billion.
Cash & Marketable Securities$3.50M
Total Debt$301.66K
Net Cash-$3.20M
Net Cash Per Share-$1.86
Tangible Book Value Per Share-$5.78K
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Ensysce Biosciences is , which is 11.43% higher than the current price. The consensus rating is
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast133.58%
EPS Growth Forecast82.60%